Published in TB and Outbreaks Week, March 23rd, 2004
According to recent research from the United States, "Few studies assess the effectiveness of HAART on reducing the incidence and recurrence of oral lesions."
D. Greenspan and coauthors at the University of California-San Francisco "investigated such changes among 503 HIV+ women over 6 years in the Women's Interagency HIV Study."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.